These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 17592313

  • 1. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Trattler W, McDonald M.
    Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
    [Abstract] [Full Text] [Related]

  • 2. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Lindstrom R, Holland E, Lane S, Raizman M, Reilly C.
    Cornea; 2008 Apr; 27(3):385-6; author reply 386-7. PubMed ID: 18362679
    [No Abstract] [Full Text] [Related]

  • 3. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Toyos R.
    Cornea; 2008 Apr; 27(3):384; author reply 384-5. PubMed ID: 18362678
    [No Abstract] [Full Text] [Related]

  • 4. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV, Westfield KC, Chalkley TH.
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
    Colin J, Paquette B.
    Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
    [Abstract] [Full Text] [Related]

  • 6. Effect of nepafenac sodium 0.1% on delayed corneal epithelial healing and haze after photorefractive keratectomy: retrospective comparative study.
    Jalali S, Yuen LH, Boxer Wachler BS.
    J Cataract Refract Surg; 2008 Sep; 34(9):1542-5. PubMed ID: 18721717
    [Abstract] [Full Text] [Related]

  • 7. Ketorolac versus nepafenac in cataract surgery.
    McCulley JP.
    J Cataract Refract Surg; 2008 Mar; 34(3):345-6; author reply 346. PubMed ID: 18299048
    [No Abstract] [Full Text] [Related]

  • 8. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, El-Defrawy SR.
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [Abstract] [Full Text] [Related]

  • 9. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS, Kennard MG, Boghossian AJ.
    Adv Ther; 2007 Sep; 24(6):1278-85. PubMed ID: 18165210
    [Abstract] [Full Text] [Related]

  • 10. Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: a bilateral, prospective, randomized, masked trial.
    Caldwell M, Reilly C.
    J Refract Surg; 2008 Apr; 24(4):377-82. PubMed ID: 18500088
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification.
    Bucci FA, Waterbury LD, Amico LM.
    Am J Ophthalmol; 2007 Jul; 144(1):146-7. PubMed ID: 17601444
    [Abstract] [Full Text] [Related]

  • 12. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
    Bucci FA, Waterbury LD.
    Curr Med Res Opin; 2011 Dec; 27(12):2235-9. PubMed ID: 21992076
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
    Solomon KD, Donnenfeld ED, Raizman M, Sandoval HP, Stern K, VanDenburgh A, Cheetham JK, Schiffman R, Ketorolac Reformulation Study Groups 1 and 2.
    J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Epi-LASIK and off-flap Epi-LASIK for the treatment of low and moderate myopia.
    Kalyvianaki MI, Kymionis GD, Kounis GA, Panagopoulou SI, Grentzelos MA, Pallikaris IG.
    Ophthalmology; 2008 Dec; 115(12):2174-80. PubMed ID: 19041475
    [Abstract] [Full Text] [Related]

  • 15. Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy.
    Donnenfeld ED, Holland EJ, Durrie DS, Raizman MB.
    Adv Ther; 2007 Dec; 24(4):852-62. PubMed ID: 17901034
    [Abstract] [Full Text] [Related]

  • 16. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
    Lane SS, Modi SS, Lehmann RP, Holland EJ.
    J Cataract Refract Surg; 2007 Jan; 33(1):53-8. PubMed ID: 17189793
    [Abstract] [Full Text] [Related]

  • 17. Effect of nepafenac eye drops on pain associated with pterygium surgery.
    Ozcimen M, Sakarya Y, Goktas S, Sakarya R, Yener HI, Bukus A, Demir LS.
    Eye Contact Lens; 2015 May; 41(3):187-9. PubMed ID: 25603438
    [Abstract] [Full Text] [Related]

  • 18. Acular LS before and during LASIK for the control of pain: a randomized, masked contralateral eye trial.
    Dougherty PJ.
    J Refract Surg; 2009 Feb; 25(2):210-3. PubMed ID: 19241772
    [Abstract] [Full Text] [Related]

  • 19. Topical ketorolac tromethamine in the reduction of adverse effects of laser in situ keratomileusist.
    Kosrirukvongs P, Prabhasawat P, Srivannaboon S, Pornpanich K.
    J Med Assoc Thai; 2001 Jun; 84(6):804-10. PubMed ID: 11556458
    [Abstract] [Full Text] [Related]

  • 20. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.
    Kim SJ, Lo WR, Hubbard GB, Srivastava SK, Denny JP, Martin DF, Yan J, Bergstrom CS, Cribbs BE, Schwent BJ, Aaberg TM.
    Arch Ophthalmol; 2008 Sep; 126(9):1203-8. PubMed ID: 18779478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.